Rydapt 00078-0698-19
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Capsule, Liquid Filled
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 28, 2017
- Listing Expires
- December 31, 2027
- Application
- NDA207997
Need to source Rydapt? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Midostaurin | 25 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Receptor Tyrosine Kinase Inhibitors [MoA]
Selected Package
00078-0698-19Selected4 CARTON in 1 CARTON (0078-0698-19) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)
Other packages for this product(1)
2 CARTON in 1 CARTON (0078-0698-99) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)